Guanghui Xu

Guanghui Xu

Auto-generated profile, based on publicly available information

Guanghui Xu

School of Pharmaceutical Science Southern Medical University Guangzhou China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
XPXianmei Pan
Xianmei Pan
BWBo Wu
Bo Wu
XFXianglin Fan
Xianglin Fan
GXGuanghui Xu
Guanghui Xu
COCaiwen Ou
Caiwen Ou
MCMinsheng Chen
Minsheng Chen
Yes‐associated protein (YAP), a major effector of the Hippo signalling pathway, is widely implicated in vascular pathophysiology processes. Here, we identify a new role of YAP in the regulation of vascular senescence. The inhibition or deficiency and overexpression of YAP were performed in human umbilical vein endothelial cells (HUVECs) and isolated vascular tissues. Cellular and vascular senescence was assessed by analysis of the senescence‐associated β‐galactosidase (SA‐β‐gal) and expression of senescence markers P16, P21, P53, TERT and TRF1. We found that YAP was highly expressed in old vascular tissues, inhibition and knockdown of YAP decreased senescence, while overexpression of YAP increased the senescence in both HUVECs and vascular tissues. In addition, autophagic flux blockage and mTOR pathway activation were observed during YAP‐induced HUVECs and vascular senescence, which could be relieved by the inhibition and knockdown of YAP. Moreover, YAP‐promoted cellular and vascular senescence could be relieved by mTOR inhibition. Collectively, our findings indicate that YAP may serve as a potential therapeutic target for ageing‐associated cardiovascular disease.

5 May 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
FFFan Feng
Fan Feng
YTYangzi Tian
Yangzi Tian
ZLZhen Liu
Zhen Liu
GXGuanghui Xu
Guanghui Xu
SLShushang Liu
Shushang Liu
HZHongwei Zhang
Hongwei Zhang
Clinicopathological features and prognosis of colonic gastrointestinal stromal tumors: evaluation of a pooled case series

26 April 2018 in Digestive Surgery
Verified
Journal Article
Closed access
PDF file
FFFan Feng
Fan Feng
FWFei Wang
Fei Wang
QWQiao Wang
Qiao Wang
GZGaozan Zheng
Gaozan Zheng
GXGuanghui Xu
Guanghui Xu
HZHongwei Zhang
Hongwei Zhang
Background: Data about the clinicopathological features and prognosis of gastrointestinal stromal tumors (GISTs) located in jejunum and ileum are lacking. The present study aims to investigate the features and prognosis of jejunal and ileal GISTs based on the Surveillance, Epidemiology, and End Results (SEER) database. Patients and Methods: Cases of jejunal and ileal GISTs were extracted from SEER database. Clinicopathological characteristics and survival data of patients were recorded. The clinicopathological features and prognosis of patients were analyzed. Results: There were 399 male (56.8%) and 303 female (43.2%). The median age was 60 years (17–96). Four hundred and seventy-two tumors were located in the jejunum (67.2%) and 230 tumors in the ileum (32.8%). The median tumor size was 7.0 cm (0.5–90). The 5-, 10-, and 20-year disease specific survival (DSS) was 84.4, 71.2, and 54.2% respectively. Clinicopathological features were comparable between tumors located in the jejunum and ileum (all p > 0.05) except gender and tumor size (both p < 0.05). Jejunal GISTs, rather than ileal GISTs (p = 0.043), were commonly found in the males. The tumor size of jejunal GISTs was smaller than that of ileal GISTs (p = 0.010). The DSS of jejunal GISTs was comparable to that of ileal GISTs (p = 0.269). Conclusions: Jejunal GISTs were more common than ileal GISTs. The prognosis was comparable between jejunal and ileal GISTs.

1 March 2018 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
GXGuanghui Xu
Guanghui Xu
FFFan Feng
Fan Feng
SLShushang Liu
Shushang Liu
FWFei Wang
Fei Wang
GZGaozan Zheng
Gaozan Zheng
HZHongwei Zhang
Hongwei Zhang
Background: Little is known about the clinicopathological features and prognosis in elderly gastric cancer (GC) patients aged 65–79 years. The aim of this study was to evaluate clinicopathological features and prognosis in elderly GC patients. Patients and methods: From May 2008 to December 2014, a total of 5,282 GC patients were enrolled in our present study. Patients were divided into elderly and middle-aged groups. The clinicopathological features and clinical outcomes were analyzed.
Results:
The proportion of dysphagia was significantly higher in elderly patients than that in middle-aged patients (P=0.002), whereas the proportion of abdominal pain and heartburn was significantly lower in elderly patients than that in middle-aged patients (P0.05). Age, tumor size, histological type, tumor depth, lymph node metastasis, carcinoembryonic antigen, alpha fetoprotein, CA19-9, and CA125 were independent risk factors for the prognosis of GC patients in univariate and multivariate analyses. Overall survival in elderly patients was significantly reduced compared with middle-aged patients (P=0.001), especially in patients with tumor size >5 cm (P=0.002), poorly differentiated tumor (P<0.000), stage III tumor (P=0.002), or normal levels of carcinoembryonic antigen (P=0.009), alpha fetoprotein (P=0.002), CA19-9 (P=0.002), and CA125 (P=0.004). Conclusion: The clinicopathological features of elderly patients were different to those of middle-aged patients. The prognosis for elderly GC patients was significantly worse than for middle-aged patients.

15 January 2016 in Chemistry of Natural Compounds
Verified
Journal Article
Closed access
PDF file
Chuan-Ling SiChuan-Ling Si
Chuan-Ling Si
GXGuang-Hui Xu
Guang-Hui Xu
XHXiao-Feng Huang
Xiao-Feng Huang
ZDZhen-Guo Du
Zhen-Guo Du
LWLei Wu
Lei Wu
Weicheng HuWeicheng Hu
Weicheng Hu